The USC Norris Comprehensive Cancer Center (NCCC) has a well-developed system for program planning and evaluation and uses several kinds of activities, supported in part by the CCSG Program Planning and Evaluation budget, to conduct its program planning and evaluation: meetings with its External Advisory Committee; offsite retreats for the overall Cancer Center Leadership plus invited guests and for specific programs; monthly meetings of the Executive Committee (the Director, Associate Directors, Medical Director of the Norris Cancer Hospital, and Chair of the Cancer Survivorship Advisory Council); and monthly meetings of the Cancer Center Leadership Council {.he Director, Associate Directors and Program Leaders). In compliance with the CCSG Guidelines, we plan to convene a meeting of our External Advisory Committee once a year. This will enable the EAC to be closely involved in our planning and implementation processes and better able to evaluate our accomplishments. We are requesting sufficient funds to bring each of them or a substitute ad hoc reviewer to the Cancer Center annually. We will continue to support our monthly Leadership Council dinner meetings to facilitate the scientific exchanges and program planning. We also plan to continue the biennial off-site Leadership Retreat in 2010 (with the current CCSG budget), 2012 and 2014. These retreats have been extremely valuable in setting the Cancer Center's scientific agenda, building camaraderie among Center leaders and encouraging collaborative inter-programmatic research. In the intervening years, we will support retreats for programs, either individually or jointly.

Public Health Relevance

The Planning and Evaluation Funds supports the strategic planning activities of the NCCC. The Cancer Center facilitates the discovery and development of more effective approaches to cancer prevention, diagnosis, and treatment, as well as deliver medical advances to patients and their families, educate health care professionals and the public, and reach out to underserved populations

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-37
Application #
8555586
Study Section
Subcommittee G - Education (NCI)
Project Start
1996-12-01
Project End
2015-11-30
Budget Start
2012-02-10
Budget End
2012-11-30
Support Year
37
Fiscal Year
2012
Total Cost
$70,582
Indirect Cost
$25,526
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Ricker, Charité N; Koff, Rachel B; Qu, Chenxu et al. (2018) Patient communication of cancer genetic test results in a diverse population. Transl Behav Med 8:85-94
Valentin-Torres, Alice; Savarin, Carine; Barnett, Joslyn et al. (2018) Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation. J Neuroinflammation 15:121
Tobin, Jessica; Miller, Kimberly A; Baezconde-Garbanati, Lourdes et al. (2018) Acculturation, Mental Health, and Quality of Life among Hispanic Childhood Cancer Survivors: A Latent Class Analysis. Ethn Dis 28:55-60
Jayne, Jordanna G; Bensman, Timothy J; Schaal, Justin B et al. (2018) Rhesus ?-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment. Am J Respir Cell Mol Biol 58:310-319
Lee, Brian H; Stallcup, Michael R (2018) Different chromatin and DNA sequence characteristics define glucocorticoid receptor binding sites that are blocked or not blocked by coregulator Hic-5. PLoS One 13:e0196965
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Woodham, Andrew W; Cheloha, Ross W; Ling, Jingjing et al. (2018) Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses. Cancer Immunol Res 6:870-880
Matsusaka, S; Wu, A H; Cao, S et al. (2018) Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. Pharmacogenomics J 18:262-269
Vannini, Ivan; Fanini, Francesca; Fabbri, Muller (2018) Emerging roles of microRNAs in cancer. Curr Opin Genet Dev 48:128-133
Veyseh, Maedah; Ricker, Charite; Espenschied, Carin et al. (2018) Secondary Germline Finding in Liquid Biopsy of a Deceased Patient; Case Report and Review of the Literature. Front Oncol 8:259

Showing the most recent 10 out of 842 publications